Business Context and Reporting Period
This Form 8-K Current Report was filed by Fluidigm Corporation (not Standard BioTools Inc.) on May 25, 2021. The report details the results of the company's 2021 Annual Meeting of Stockholders held on the same date.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders representing approximately 76.53% of the outstanding common stock (57,372,547 shares) participated in the Annual Meeting. Four matters were voted upon:
- Election of Class II Directors: Gerhard F. Burbach, Carlos Paya, M.D., Ph.D., and Ana K. Stankovic, M.D., Ph.D., MSPH were elected to serve until the 2024 annual meeting.
- Executive Compensation: The advisory vote to approve executive compensation for the year ended December 31, 2020, was approved.
- Equity Incentive Plan Amendment: Stockholders approved an amendment to the 2011 Equity Incentive Plan to increase the number of shares reserved for issuance by 4,075,000 shares.
- Accounting Firm Ratification: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2021, was ratified.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors. The document serves as a formal record of the stockholder vote and the amendment to the equity plan.
Important Facts for Investors to Verify
- Verify the impact of the 4,075,000 share increase to the 2011 Equity Incentive Plan on potential future dilution.
- Review the full text of the amended 2011 Equity Incentive Plan (Exhibit 10.1) for material terms.
- Confirm the tenure of the newly elected Class II directors through the 2024 annual meeting.
- Note that this filing does not contain financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.